FDA's Arthritis Drugs Advisory Committee recommends Celebrex approval

Share this article:
The FDA's Arthritis Drugs Advisory Committee has voted to recommend approval of Pfizer's Celebrex for use in juvenile rheumatoid arthritis, despite long-term safety concerns. They recommended that, if approved, Pfizer continues to study long-term safety and establish a patient registry.

Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.